期刊
SEMINARS IN IMMUNOPATHOLOGY
卷 43, 期 1, 页码 135-157出版社
SPRINGER HEIDELBERG
DOI: 10.1007/s00281-020-00822-z
关键词
-
资金
- Clinical Lectureship from NIHR
- MRC [MR/S036407/1]
- MRC [MR/S036407/1] Funding Source: UKRI
This article investigates the relationship between thymic selection and the pathogenesis of central nervous system autoimmune diseases. Both animal models and clinical data suggest that thymic function plays a role in susceptibility to these diseases. However, a better understanding of this relationship is still needed.
Autoimmune diseases of the central nervous system (CNS) are associated with high levels of morbidity and economic cost. Research efforts have previously focused on the contribution of the peripheral adaptive and innate immune systems to CNS autoimmunity. However, a failure of thymic negative selection is a necessary step in CNS-reactive T cells escaping into the periphery. Even with defective thymic or peripheral tolerance, the development of CNS inflammation is rare. The reasons underlying this are currently poorly understood. In this review, we examine evidence implicating thymic selection in the pathogenesis of CNS autoimmunity. Animal models suggest that thymic negative selection is an important factor in determining susceptibility to and severity of CNS inflammation. There are indirect clinical data that suggest thymic function is also important in human CNS autoimmune diseases. Specifically, the association between thymoma and paraneoplastic encephalitis and changes in T cell receptor excision circles in multiple sclerosis implicate thymic tolerance in these diseases. We identify potential associations between CNS autoimmunity susceptibility factors and thymic tolerance. The therapeutic manipulation of thymopoiesis has the potential to open up new treatment modalities, but a better understanding of thymic tolerance in CNS autoimmunity is required before this can be realised.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据